The revenue also represents a 39 percent increase from revenues in the third quarter of 2012. Domestic revenues from 2012 fourth quarter are approximately $3 million with international revenue at $1.1 million.
In 2013, providers can begin using the new Category 1 code for the company’s AxiaLIF technology.
More Articles on Devices:
ArthroCAD Completes Financing Round for Total Hip Arthroplasty Development
Hydrocision’s Spine Device Now Available for Herniated Disc Pain Relief
FDA Grants Clearance to Two VertiFlex Spine Systems
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.